{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T15:11:49Z","timestamp":1779289909493,"version":"3.51.4"},"reference-count":23,"publisher":"LLC Obyedinennaya Redaktsiya","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ter. arkh."],"published-print":{"date-parts":[[2017]]},"DOI":"10.17116\/terarkh201789678-83","type":"journal-article","created":{"date-parts":[[2017,7,24]],"date-time":"2017-07-24T11:55:31Z","timestamp":1500897331000},"page":"78","source":"Crossref","is-referenced-by-count":2,"title":["Efficiency of different celecoxib regimens in patients with active axial spondyloarthritis: Results of the 4-week pilot open-label comparative single-center study \u00abAIM\u00bb"],"prefix":"10.26442","volume":"89","author":[{"given":"I. Z.","family":"Gaydukova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u041a. A.","family":"Gamayunova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. D.","family":"Dorogoykina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P.","family":"Rebrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","reference":[{"key":"key-10.17116\/terarkh201789678-83-1","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2015-657-660"},{"key":"key-10.17116\/terarkh201789678-83-2","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210770"},{"key":"key-10.17116\/terarkh201789678-83-3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203860"},{"key":"key-10.17116\/terarkh201789678-83-4","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2015.1039514"},{"key":"key-10.17116\/terarkh201789678-83-5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1702534"},{"key":"key-10.17116\/terarkh201789678-83-6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.764530"},{"key":"key-10.17116\/terarkh201789678-83-7","doi-asserted-by":"publisher","DOI":"10.14412\/1996-7012-2016-3-41-46"},{"key":"key-10.17116\/terarkh201789678-83-8","unstructured":"Gaidukova IZ, Rebrov AP, Khondkaryan EV, Aparkina AV. Efficacy and cardiovascular safety of amtolmetin guacil in the treatment of patients with ankylosing spondylitis: final results of KORONA study. Pharmateka. 2016;7(320):53-58. (In Russ.)"},{"key":"key-10.17116\/terarkh201789678-83-9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.764530"},{"key":"key-10.17116\/terarkh201789678-83-10","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2012.02.001"},{"key":"key-10.17116\/terarkh201789678-83-11","doi-asserted-by":"crossref","unstructured":"MacDonald TM, Hawkey CJ, Ford I, et al. Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT). Eur Heart J. 2016.","DOI":"10.1093\/eurheartj\/ehw387"},{"key":"key-10.17116\/terarkh201789678-83-12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003585"},{"key":"key-10.17116\/terarkh201789678-83-13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108233"},{"key":"key-10.17116\/terarkh201789678-83-14","unstructured":"Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol. 1994;21(12):2286-2291."},{"key":"key-10.17116\/terarkh201789678-83-15","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.100826"},{"key":"key-10.17116\/terarkh201789678-83-16","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138594"},{"key":"key-10.17116\/terarkh201789678-83-17","unstructured":"Calin A, Garrett S, Whitelock H, Kennedy LG, et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol. 1994;21(12):2281-2285."},{"key":"key-10.17116\/terarkh201789678-83-18","unstructured":"Rebrov OY, ed. In: Rebrov O. Statistical analysis of medical data. The application package STATISTICA applications. M.: Media Sphere; 2002. (In Russ.)"},{"key":"key-10.17116\/terarkh201789678-83-19","doi-asserted-by":"crossref","unstructured":"Sieper J, Klopsch T, Richter M, Kapelle A, Rudwaleit M, Schwank S, Regourd E, May M.Comparison of two different dosages of celecoxib with diclofenac for the treatment of active ankylosing spondylitis: results of a 12-week randomised, double-blind, controlled study. Ann Rheum Dis. 2008;67(3):323-329.","DOI":"10.1136\/ard.2007.075309"},{"key":"key-10.17116\/terarkh201789678-83-20","doi-asserted-by":"publisher","DOI":"10.1177\/0300060516628704"},{"key":"key-10.17116\/terarkh201789678-83-21","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.11.009"},{"key":"key-10.17116\/terarkh201789678-83-22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.133488"},{"key":"key-10.17116\/terarkh201789678-83-23","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.7.4.401"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,6,28]],"date-time":"2020-06-28T21:26:47Z","timestamp":1593379607000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.mediasphera.ru\/issues\/terapevticheskij-arkhiv\/2017\/6\/downloads\/ru\/1004036602017061078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"alternative-id":["terarkh201789678-83"],"URL":"https:\/\/doi.org\/10.17116\/terarkh201789678-83","relation":{},"ISSN":["0040-3660"],"issn-type":[{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}